Mammogram Screening Risks and Benefits for Women Under 50
Author Information
Author(s): Berrington de González A, Reeves G
Primary Institution: Cancer Research UK Epidemiology Unit, University of Oxford
Hypothesis
Is mammographic screening before age 50 beneficial compared to its radiation risks?
Conclusion
Annual mammographic screening before age 40 may increase breast cancer deaths, while starting at age 40 could reduce them if mortality is significantly lowered.
Supporting Evidence
- Screening before age 50 is less effective and carries higher radiation risks.
- A decade of screening starting at age 20 or 30 could lead to more deaths than it prevents.
- Starting screening at age 40 may reduce deaths if mortality is reduced by 20% or more.
Takeaway
Getting mammograms before age 40 might do more harm than good, but starting at 40 could help if it really reduces deaths from breast cancer.
Methodology
The study estimated radiation-induced breast cancer deaths and compared them with deaths prevented by screening using a risk model and data from trials.
Potential Biases
Potential underestimation of radiation risks for women with a family history of breast cancer.
Limitations
The calculations were based on uncertain parameters and assumptions about breast cancer mortality reduction.
Participant Demographics
Women in the UK, particularly those under 50 and those with a family history of breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website